staurosporine has been researched along with erastin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, AJ; Boniface, JJ; Fridman, DJ; Lessnick, SL; Peltier, JM; Sahasrabudhe, S; Smith, R; Smukste, I; Stockwell, BR; von Rechenberg, M; Wolpaw, AJ; Yagoda, N; Yang, WS; Zaganjor, E | 1 |
| Hayano, M; Shimada, K; Skouta, R; Stockwell, BR | 1 |
2 other study(ies) available for staurosporine and erastin
| Article | Year |
|---|---|
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
Topics: Cell Death; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Humans; Ion Channel Gating; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Phosphorylation; Piperazines; raf Kinases; ras Proteins; Sensitivity and Specificity; Signal Transduction; Voltage-Dependent Anion Channel 2 | 2007 |
Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death.
Topics: Antineoplastic Agents; Carbolines; Cell Death; Cell Line, Tumor; Cell Survival; Drug Design; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Neoplasms | 2012 |